Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 10/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL29488102 | 0.98 | ACHE (0.95) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30945416 | 0.98 | ACHE (0.95) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28469713 | 0.98 | ACHE (0.95) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Water SCHEMBL11727004 | 0.98 | ACHE (0.95) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Dimethylcarbate SCHEMBL4413046 | 0.83 | ACHE (0.69) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Dimethylcarbate SCHEMBL4413044 | 0.82 | ACHE (0.67) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| SCHEMBL26628889 | 0.81 | ACHE (0.67) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL8009388 | 0.78 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL29627074 | 0.78 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 | |
| Edrophonium SCHEMBL34790 | 0.78 | ACHE (1.00) | ACHETSHROPRM1BLMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | claimed |
| EP-1904109-B1 | SELF-STERILIZING PRODUCTS | MOLTENI & C (IT) | 2013-04-03 | — | — | EP | claimed |
| EP-1904060-B1 | USE OF PHTHALOCYANINE DERIVATES FOR THE NON-PHOTODYNAMIC TREATMENT OF DISEASES | MOLTENI & C (IT) | 2011-06-01 | — | — | EP | claimed |
| US-20090130049-A1 | Self-Sterilizing Products | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | claimed |
| EP-1164135-B1 | Substituted metal-phthalocyanines, their preparation and the use thereof | MOLTENI & C (IT) | 2004-02-18 | — | — | EP | claimed |
| US-20230149294-A1 | READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE | SLAYBACK PHARMA LLC (US) | 2023-05-18 | — | — | US | disclosed |
| US-20150126703-A1 | CATALYZED POLYMERIZATION OF CYCLIC ESTERS AND CYCLIC CARBONATES | UNIVERSITE DE MONS (BE) | 2015-05-07 | — | — | US | disclosed |
| US-20150126703-A1 | CATALYZED POLYMERIZATION OF CYCLIC ESTERS AND CYCLIC CARBONATES | UNIVERSITE DE MONS (BE) | 2015-05-07 | — | — | US | disclosed |
| US-8741264-B2 | Self-sterilizing products | MOLTENI THERAPEUTICS S.R.L. (IT) | 2014-06-03 | — | — | US | disclosed |
| EP-1904109-B1 | SELF-STERILIZING PRODUCTS | MOLTENI & C (IT) | 2013-04-03 | — | — | EP | disclosed |
| WO-2011012698-A2 | PHTHALOCYANINE DERIVATIVE CONSISTING OF A MIXTURE OF 4 ISOMERS | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2011-02-03 | — | — | WO | disclosed |
| US-20090130049-A1 | Self-Sterilizing Products | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO S.P.A. (IT) | 2009-05-21 | — | — | US | disclosed |
| US-7422694-B2 | Process for the microbiological decontamination of water by means of photosensitive agents | SALBERT CO., LTD. (CN) | 2008-09-09 | — | — | US | disclosed |
| US-4134792-A | Specific binding assay with an enzyme modulator as a labeling substance | MILES LABORATORIES, INC. (US) | 1979-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149294-A1 | READY-TO-USE INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING NEOSTIGMINE AND GLYCOPYRROLATE | CHRNA5, CHRNB4, CHRNB1 | ACHE 25/4885TSHR 278/4885OPRM1 223/4885 |
| US-20090130049-A1 | Self-Sterilizing Products | NASP, ZP1, SPAG5 | ACHE 4720/4885TSHR 4384/4885OPRM1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.